Method for preparation of thrombin
US-2018016567-A1 · Jan 18, 2018 · US
US9447402B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9447402-B2 |
| Application number | US-201414202046-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 10, 2014 |
| Priority date | Mar 15, 2013 |
| Publication date | Sep 20, 2016 |
| Grant date | Sep 20, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a method for producing recombinant prothrombin. The method comprises: providing a vector DNA into which a gene encoding a tag and a gene encoding prothrombin are incorporated, wherein the tag is selected from the group consisting of MBP, SUMO, and NusA; and expressing a tag fusion type prothrombin in a lepidopteran insect or cultured cells of the lepidopteran insect.
Opening claim text (preview).
What is claimed is: 1. A method for producing recombinant prothrombin, comprising: providing a vector DNA into which a gene encoding a tag and a gene encoding prothrombin are incorporated, wherein the tag is selected from the group consisting of MBP, SEQ ID NO: 2, and NusA; and expressing a tag fusion type prothrombin in a lepidopteran insect or cultured cells of the lepidopteran insect. 2. The method according to claim 1 , further comprising: obtaining a soluble fraction containing the tag fusion type prothrombin from the lepidopteran insect or the cultured cells of the lepidopteran insect after the expressing step. 3. The method according to claim 1 , wherein the gene encoding a tag is incorporated into the vector DNA so that the tag is fused to the N terminal of prothrombin. 4. The method according to claim 1 , wherein a gene encoding a polypeptide having the amino acid sequence set forth in any one of SEQ ID NOS: 7 to 9 is incorporated into the vector DNA. 5. The method according to claim 1 , wherein the lepidopteran insect is Bombyx mori. 6. The method according to claim 1 , wherein the expressing step comprises infecting the lepidopteran insect or the cultured cells of the lepidopteran insect with a baculovirus comprising the vector DNA. 7. The method according to claim 1 , wherein a gene encoding a protein secretory signal sequence is incorporated into the vector DNA. 8. The method according to claim 7 , wherein the protein secretory signal sequence is at least one selected from the group consisting of a prothrombin-derived secretory signal sequence, a Bombyx mori -derived 30K signal sequence, and a Bombyx mori -derived SP signal sequence.
Thrombin (3.4.21.5) · CPC title
containing a tag with affinity for a non-protein ligand · CPC title
viral genome or elements thereof as genetic vector · CPC title
containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin · CPC title
Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.